2014 Research Grants

research-grantsThe Isaac Foundation is pleased to announce two research grant opportunities with a call for a $100,000 grant through our general MPS Fund and a call for $50,000 from our MPS II Research Fund.

Last month also saw us renew a research project for $50,000, bringing our total research grants from The Isaac Foundation early 2014 to $200,000!

We continue to be proud of the work that we do in the MPS Community. To date, we are well over 1/2 million dollars granted to research projects throughout the world and we will continue to grow and support innovative research until a cure for MPS is found.

Calls for Applications to these grants will be issued soon.

We are also very pleased to announce that Dr. Barbara Burton and Dr. Paul Harmatz, both world-renowned MPS specialist from the United States, have joined our Medical Advisory panel to review and advise on research applications as they come in. Dr. Burton and Dr. Harmatz join Dr. Julian Raiman and Dr. Joe Clarke to round out our 2014 Medical Advisory Panel.

More details to follow soon. Thanks for you continued support as we seek to find a cure for our kids!

Congrats, John Mayer.

1604541_10152000956072725_1069045482_nHey Everyone,

Just a post to  congratulate Isaac’s longtime pal, John Mayer, for being asked to perform at the Beatles Tribute that aired on television last night.  Being asked to be a part of recognizing an iconic band like The Beatles isn’t small potatoes, and we couldn’t think of a better person to hit the stage in tribute.

Oh – it was nice to see the strap the boys had made for John as well.  It looks great, and the boys are always so happy to see him using it.  It was made and given out of love, and we’re thrilled it gets a bit of use.

Take Care!

A.

The Pass

We-are-all-in-the-gutterI just had a touching moment with Isaac, another one of those beautiful moments when I marvel at how incredibly insightful and thoughtful he is.

Everyone who knows Isaac knows that he loves music.  John’s his favourite, followed by Danny Michel and Adele.  But he loves all music, and listens intently to the lyrics, often wondering about their meaning.  He gets emotional, sometimes, at the sad songs, and he rocks out to the fun ones.

It’s easy for him, too, because we always have music on in the house.  Or in the car.  Or garage, or outside.  Music is everywhere in our life, which is probably why we’ve made it a central component of our Gala For A Cure every year.

A few minutes ago, Isaac popped over and asked “Dad, which song was it that made you want to start The Isaac Foundation?”  I was surprised – I haven’t told too many people when and how The Isaac Foundation came into being.  But I have told those close to me – probably in one of my many emotional or reflective or “softy” moments.  And I should remember that Isaac sees and hears EVERYTHING.  It should come as no surprise that he’s heard me tell the story before.  But he’s kept it inside; pondering, perhaps, how a song could start someone on the journey we’ve found ourselves on.

I smiled and told him I’d put it on for him.  We listened, but he wanted to know EXACTLY what about the song made me want to start our charity, and our search for a cure.  We skipped back to the start of the song and listened closely together, reading the lyrics on the screen at the same time.  I watched him tear up as he read, and I described the moments in the song that woke me up out of my grieving, the message that got me the hell out of bed and on my way to finding a cure

Whenever I put that song on, I’m always transported back to those days after diagnosis – the awful, dark days when I couldn’t get out of bed.  The weeks that I couldn’t eat (I lost 40 pounds quickly).  The haunting nightmares I had, the dark, dark places my mind took me to.  I remember driving through a dark February night, watching the stars, and trying to escape with some music.  And I remember this song coming on and knocking some sense into me.  I decided on that night that I wasn’t going to lay around and feel sorry for myself.  My son, after all, wasn’t going to get better by me sitting around and waiting for the disease to take hold in him.  Simply put, that February night changed my life.

Going back in time to that night always brings such mixed emotion, and it felt a bit surreal sitting beside the boy I’ve worked so hard to save and reliving it.

Isaac and I finished listening to the song together and we sat quietly for a long moment.  He looked up at me and said “Dad.  Would I be dead right now if you didn’t hear that song?”  My heart aching, I told him no – I would have woken up sooner or later, and we would have figured this out either way.  But I’m glad I heard that song that night.  It’s provided me a turning point I can always look back on, and a reminder to always keep going forward, no matter what (or who) gets in the way.

There’s still many nights I want to cry out “Christ, what have you done?” just like in the song.  More nights than I know what to do with.  But there’s also many more  nights when I remember the Oscar Wilde quote about all of us being stuck in the gutter, and only some of us turning to look at the stars (portrayed in my inspiration song, too).

My boy never ceases to amaze me.  He is insightful beyond his years.  And as we head into our Gala next weekend, and start our journey with our new Non-Profit (announcement soon!), I’m glad he waited until today to ask me about my inspiration for The Isaac Foundation.  I needed to slow down and remember WHY we’re doing what we’re doing, and I’m glad I did.

Song and lyrics are below.  See many of you next week in person or via our Live Stream from the Gala.

Thanks, as always, for your support.

With Love,

A.

“The Pass”

Proud swagger out of the school yard
Waiting for the world’s applause
Rebel without a conscience
Martyr without a causeStatic on your frequency
Electrical storm in your veins
Raging at unreachable glory
Straining at invisible chainsAnd now you’re trembling on a rocky ledge
Staring down into a heartless sea
Can’t face life on a razor’s edge
Nothing’s what you thought it would be

All of us get lost in the darkness
Dreamers learn to steer by the stars
All of us do time in the gutter
Dreamers turn to look at the cars
Turn around and turn around and turn around
Turn around and walk the razor’s edge
Don’t turn your back
And slam the door on me

It’s not as if this barricade
Blocks the only road
It’s not as if you’re all alone
In wanting to explode

Someone set a bad example
Made surrender seem all right
The act of a noble warrior
Who lost the will to fight

And now you’re trembling on a rocky ledge
Staring down into a heartless sea
Done with life on a razor’s edge
Nothing’s what you thought it would be

No hero in your tragedy
No daring in your escape
No salutes for your surrender
Nothing noble in your fate
Christ, what have you done?

#Hope

ea04e4d838d111e38a6422000a1f971a_8Hi Everyone,

Ever wonder what HOPE looks like?  We saw it first hand today.  It looks like hundreds of people in a small community gathered to support a little boy who suffers from MPS II.  It looks like bouncy castles, sugar shacks, candy mountains, dunk tanks, fire trucks, police cars, games rooms, and magicians!  It looks like strangers donating money that some can’t spare to help us find a cure for MPS.  And while HOPE can take on many forms, I was so proud of the form it took today.

photo 1-4We spent the morning and afternoon at Jack’s Family Fun Fair, an event organized by the family of Jack Higginson, the little boy who was diagnosed with MPS II this summer who we’ve had the fortune of getting to know.  Jack’s aunts, Courtney, Sarah, Lee, and Emily, as well as many other family members, worked tirelessly over the past few months to pull this together.  Money raised is going to support Jack’s family as they deal with the high cost of treating this disease, and they will be making a donation to The Isaac Foundation’s MPS II Fund, which is co-ordinated and created by the equally amazing Deb and Ryan Purcell.

We had a fantastic time.  The boys took in all of the activities, dunked Jack’s dad in the Dunk Tank (twice!), and really enjoyed their time with Jack.  The Higginson family all did interviews for local television and did a fantastic job of spreading awareness of this disease and educating the public about how incredibly special our children are.  Everyone who attended seemed to really enjoy themselves.  The Higginson’s should be proud.  They’ve brought us one small step closer to a cure, and I’m so happy we got to be there to see the wonderful work they did.

photo 2-3We’re looking forward to spending more time with Jack, Ben, Kristin and their entire extended family.  We’ve always vowed to find a cure for this terrible disease.  It’s nice to find more partners in our quest along the way; partners who, like us, will never give up the fight for our kids!

Drop over to www.jacksjourney.ca to read about Jack and to follow his fight.

With Love,

A.

#Courage

photo 1Hi All,

It’s been a while since I’ve done an actual blog posting – as usual, things get busy and it falls down on my list of things to do (a list that never seems to end, these days!).  However, I wanted to take a moment to post some photos of the bravest boy I know.

Isaac has given us so much to be proud of throughout his 9 years.  He’s fought MPS courageously, and always with a smile on his face.  2 am MRI’s, countless trips to the hospital, brain scans, heart appointments, neurosurgeon visits – you name it, he’s done it.  Through it all, he never complains.

Today, Isaac’s been showing his new friend Jack around the hospital.  As many of you know, Jack (www.jacksjourney.ca) was diagnosed with MPS II this summer and we’ve had the fortune of being involved with his family, chipping in with whatever small amount of support we can offer.  I’m sitting at my desk shedding tears of pride as these two photos land in my inbox, photos of my son playing “big brother” to Jack.

It’s hard to define true courage – I know Isaac is brave because I’ve witnessed how well he’s dealt with the fight of his life.  But to have the courage to open up and share your experiences with someone else, with an aim of making their fight a bit easier, shows me just how incredibly courageous he is.

Fighting a life or death battle is hard, and it’s heartbreaking as a parent to watch your child deal with the disease.  The work we do is tiring, relentless and, hopefully, making a difference.  Photos like this keep us going, and I’m glad that my son (once again) is giving us the strength to keep at it.

We’re looking forward to our time together with Jack and his family – they are fighters.  And I know we’ll be celebrating together when we find our cure for our kids.

Hope you enjoy the photos.  Share as you see fit.

The photo up top shows Isaac and Jack playing at Marnie’s Lounge at Sick Kid’s Hospital this morning before treatment.  The photo below shows Isaac getting hooked up and ready for treatment.  Jack is watching intently beside him, waiting for his turn to get hooked up and for treatment to begin.  Truly precious and priceless.

With Love from a proud Dad,

A.

photo-11

 

J&J – The Evolution of a Lovely Relationship

johnson_and_johnson_noHi All,

I’ve promised myself that I would post new blogs more often that I’ve found time for in the past.  It’s been another crazy year, for sure, but if I’m confident I can find 5 occasional minutes to blog now and then!

Just wanted to post a quick update while it was first and foremost on my mind.  I spoke with Dr. Ray at JnJ this evening and wanted to note how impressed I continue to be with the team at Janssen Pharmaceuticals and, as we’ve always referred to them as, Johnson and Johnson.  Or relationship started off, as you may remember, quite rocky.  The Isaac Foundation, along with our partner organizations, had long lobbied the company to commit to research of a highly promising drug (Elmiron) that the company makes and markets.  After repeated no answers, and constant put-offs, we put our advocacy efforts on behalf of our kids in high gear.  After months of hard work and patience, we finally had the opportunity to present our case to some decision makers within the company.  From that moment forward, things changed, as did our view on the company.

Once the potential of Elmiron was recognized by JnJ, the company acted quickly to repair any damage that was done with our organization but, more importantly, with the MPS community as a whole.  They committed to further study of their product, brought some of the most incredible MPS researchers and physicians together for a collaborative planning and educational session, and took a keen interest in our children.  They put a team together that dedicated themselves to learning about MPS and the struggles families dealing with this devastating disease face, something that I was incredibly impressed with, and continue to be proud of.

What impressed me most was that they didn’t take a serious look at this drug for financial reasons – JnJ stood to lose a lot of money during the entire endeavour.  They chose to look into this product because the data was compelling, and the impact it could have on saving our children was undeniable.  We often took aim at the JnJ Credo Values – values the company promoted and prided themselves on.  Once Dr. Amrit Ray took over the Elmiron/MPS file, that credo was put into action and the company showed me why they put such stock in their credo values.  In short – they undertook this project because it was going to positively impact the lives of our kids, and they felt it was the right thing to do.

Unfortunately, JnJ was prevented from further study of Elmiron due to legal issues relating to patents, along with Mt. Sinai’s deal with another drug company.  However, I’ve been fortunate to continue working with Dr. Ray and have had the opportunity to touch base with him on a regular basis.  He and his team continue to learn about MPS and our children, and I’m incredibly touched at how caring and compassionate he and his team have been.

I spoke with Dr. Ray this evening.  And like every time we chat, I was struck by how empathetic he is as it relates to our kids.  Johnson and Johnson is lucky to have him at the helm, and we at The Isaac Foundation are lucky that our relationship has evolved over time to find us at the place we are today.

Thanks, as always, for the support you provide us.

With Love,

A.

 

J&J – The Evolution of a Lovely Relationship

johnson_and_johnson_noHi All,

I’ve promised myself that I would post new blogs more often that I’ve found time for in the past.  It’s been another crazy year, for sure, but if I’m confident I can find 5 occasional minutes to blog now and then!

Just wanted to post a quick update while it was first and foremost on my mind.  I spoke with Dr. Ray at JnJ this evening and wanted to note how impressed I continue to be with the team at Janssen Pharmaceuticals and, as we’ve always referred to them as, Johnson and Johnson.  Or relationship started off, as you may remember, quite rocky.  The Isaac Foundation, along with our partner organizations, had long lobbied the company to commit to research of a highly promising drug (Elmiron) that the company makes and markets.  After repeated no answers, and constant put-offs, we put our advocacy efforts on behalf of our kids in high gear.  After months of hard work and patience, we finally had the opportunity to present our case to some decision makers within the company.  From that moment forward, things changed, as did our view on the company.

Once the potential of Elmiron was recognized by JnJ, the company acted quickly to repair any damage that was done with our organization but, more importantly, with the MPS community as a whole.  They committed to further study of their product, brought some of the most incredible MPS researchers and physicians together for a collaborative planning and educational session, and took a keen interest in our children.  They put a team together that dedicated themselves to learning about MPS and the struggles families dealing with this devastating disease face, something that I was incredibly impressed with, and continue to be proud of.

What impressed me most was that they didn’t take a serious look at this drug for financial reasons – JnJ stood to lose a lot of money during the entire endeavour.  They chose to look into this product because the data was compelling, and the impact it could have on saving our children was undeniable.  We often took aim at the JnJ Credo Values – values the company promoted and prided themselves on.  Once Dr. Amrit Ray took over the Elmiron/MPS file, that credo was put into action and the company showed me why they put such stock in their credo values.  In short – they undertook this project because it was going to positively impact the lives of our kids, and they felt it was the right thing to do.

Unfortunately, JnJ was prevented from further study of Elmiron due to legal issues relating to patents, along with Mt. Sinai’s deal with another drug company.  However, I’ve been fortunate to continue working with Dr. Ray and have had the opportunity to touch base with him on a regular basis.  He and his team continue to learn about MPS and our children, and I’m incredibly touched at how caring and compassionate he and his team have been.

I spoke with Dr. Ray this evening.  And like every time we chat, I was struck by how empathetic he is as it relates to our kids.  Johnson and Johnson is lucky to have him at the helm, and we at The Isaac Foundation are lucky that our relationship has evolved over time to find us at the place we are today.

Thanks, as always, for the support you provide us.

With Love,

A.

 

Thank You RBC and Arthur Lions Club!

AJR_1089The Isaac Foundation extends a huge thank you to the Arthur Lions Club and RBC for their incredibly generous donation to The Isaac Foundation through our satellite office with the More Family.  All funds donated will go directly to funding research and finding a cure for this rare and devastating disease.

The photo to the left shows Darren More with Jasper, accepting the generous donation from the Club.

 

ERT – Proof of Effectiveness From Around The World

4d5f8030f60e11e2ad2b22000ae80c6b_7The question of whether Alberta Health will fund treatment for Aleena will be based solely on whether the province wants to pay the high cost associated with their decision.  How do I know this?  Well – if they were basing their decision on evidence based science alone, they would have rendered their decision by now – and that decision would have to be a YES.  To support that claim, I thought I’d take the time to include some snippets from some of the finest MPS Researchers in the world.  These quotes are taken directly from readily-available and reputable Journals, with sources included for further study.  There is irrefutable proof that this treatment is effective. There is irrefutable proof that this treatment MUST begin at a very early stage.  Delaying a decision on providing this treatment for Aleena is detrimental to her long-term health!

Here’s some things to ponder and share.  It took me less than 1/2 day to do this review of the available scientific literature regarding the safety and effectiveness that ERT yields patients suffering from MPS VI.  How it’s taken Alberta Health over 4 weeks to find this information is beyond comprehension.  And if they didn’t find this information during their STEDT review, they haven’t done a thorough job evaluating this case at all!  I should note that this is just a small sampling of the literature that is available on the subject, and every article I dug up promotes the same overall message – ERT is the best treatment for children suffering from MPS VI, it’s EFFECTIVE, and it must begin EARLY.  One final note – all articles point to this treatment being SAFE.  With all this clinical data available, Alberta Health must simply be weighing whether they want to pay to save Aleena or not, and shame on them if that’s the case.

Please read and share.  #Treatment4Aleena

“Recently, a consensus panel of international experts in medicine, genetics and biochemistry drafted management guidelines for MPS VI.  The expert panel recommended ERT, when available, as first-line therapy.”  (Schlander, M. and Beck, M. Current Medical Research and Opinion, 2009)

 

“Within 24 weeks of treatment, most patients treated with ERT demonstrated significant and sustained improvements in performance in [6 and 12 minute walking tests].  Long-term safety data show that the therapy has an acceptable safety profile.”  (Harmatz, P.  Turkish Journal of Pediatrics, 2010)

 

“…initiating ERT at an early age is safe and improves overall morphology, clinical outcome, quality of life and the safety profile related to immune response.  The main benefit was in scoliosis, joint range of movement, cardiac valves and facial appearance.” (McGill JJ, Inwood AC, Coman DJ, Lipke ML, de Lore D, Swiedler SJ, Hopwood JJ.  Clinical Genetics, 2010)

 

“As ERT slows down the accumulation of GAG in cells and tissues, it is thought that early treatment might prevent or delay the development of irreversible disease manifestations and limit or prevent growth deceleration.”  (Harmatz, P.  Turkish Journal of Pediatrics, 2010)

 

“…this trend toward decline in pulmonary function can be halted and partially reversed during ERT…” (Harmatz, P., Yo, Z., Giugliana, R., Schwartz, V., Guffon, N., Teles, E., Miranda, C…Decker, C.  Journal of Inherited Metabolic Disease, 2009)

 

“One recently published case control study assessed the impact of [ERT] in two siblings: one treated from the age of 8 weeks, one from 3.6 years.  After 3.6 years of treatment with [ERT], the youngest child had a lack of scoliosis and preserved joint movement, cardiac valves and facial morphology, unlike the older sibling at the same age.  The older sibling had improvements in joint mobility and cardiac valve disease after 3.6 years of treatment with [ERT].”  (Harmatz, P.  Turkish Journal of Pediatrics, 2010)

 

“…it seems desirable to start treating these patients at an early stage, before irreversible damage has occurred.” (Schlander, M. and Beck, M. Current Medical Research and Opinion, 2009)

 

“[ERT] was found to be safe and effective in this young patient population and similar to that seen in clinical trials with older patients.” (Horovitz, D., Magalhaes, T., Acosta, A., Ribeiro, E., Giuliani, L., Palhares, D., Chong, K…Llerena Jr., J. Molecular Genetics and Metabolism, 2013)

 

“This improvement in respiratory function relative to baseline may lead to a decrease in the severity of respiratory illnesses and number of hospitalizations, and an overal improvement in the quality of life of MPS VI patients.” (Harmatz, P., Yo, Z., Giugliana, R., Schwartz, V., Guffon, N., Teles, E., Miranda, C…Decker, C.  Journal of Inherited Metabolic Disease, 2009)

 

“This therapy opens the door to a more proactive approach of managing the disease, i.e slowing down the accululation of GAG rather than alleviating the resulting clinical manifestations.” (Harmatz, P.  Turkish Journal of Pediatrics, 2010)

 

“…conventional cost-effectiveness criterion currently in widespread use does not offer sufficient basis for rejecting reimbursement of expensive treatments for exceptionally rare disorders.”  (Schlander, M. and Beck, M. Current Medical Research and Opinion, 2009)

 

“The prescribed dosage of 1 mg/kg IV weekly with galsulfase ERT is shown to be safe and effective in slowing and/or improving certain aspects of the disease.” (Horovitz, D., Magalhaes, T., Acosta, A., Ribeiro, E., Giuliani, L., Palhares, D., Chong, K…Llerena Jr., J. Molecular Genetics and Metabolism, 2013)

 

“[ERT] weekly has shown to be safe and effective in slowing progression and/or improving the burden of the disease for MPS VI in young children. As early treatment initiation results in improved patient outcomes in this young cohort, early recognition of the more subtle symptoms associated with slowly progressing disease should be a priority to ensure early diagnosis and treatment initiation.”  (Horovitz, D., Magalhaes, T., Acosta, A., Ribeiro, E., Giuliani, L., Palhares, D., Chong, K…Llerena Jr., J. Molecular Genetics and Metabolism, 2013)

 

“ERT positively affected mobility of the shoulder joint, the size of the liver and spleen, cardiac parameters, pulmonary function, certain domains of [quality of life], and the level of GAGs in the urine.” (Brands, M. Oussoren, E., Ruijter, G., Vollebregt, A., van den Hout, H., Joosten, K., Hop, W., Plug, I., Ploeg, A.  Molecular Genetics and Metabolism, 2013)

 

“…results of ERT treatment in MPS VI have been promising, demonstrating clinically and statistically significant improvements in endurance along with a reduction in urinary GAGs.” (Harmatz, P., Giugliani, R., Schwartz, I., Guffon, N., Teles, E., Miranda, M., Wraith, J…Decker, C.  Molecular Genetics and Metabolism, 2008)

Alberta Toddler Awaiting Funding For Life Sustaining Treatment

ALBERTA TODDLER AWAITING FUNDING FOR LIFE-SUSTAINING TREATMENT

St. Albert Toddler Diagnosed With Ultra-Rare Condition; Treatment Already Being Funded In Numerous Provinces

Alberta Health is currently considering an application for exceptional funding of an expensive life-sustaining treatment required by an Alberta toddler.  Three year-old Aleena Sadownyk was recently diagnosed with MPS VI, and requires the life-sustaining treatment immediately in order to halt further progression of her devastating disease.  Alberta Health has already denied funding for the treatment through the Alberta Rare Diseases Funding Program.  They are now reviewing a second application through the Short Term Exceptional Drug Therapy (STEDT) program.  While Aleena needs to begin treatment immediately, there has been no timeline set for a decision from Alberta Health.

Aleena suffers from a rare enzyme deficiency called MPS VI (also known as Maroteaux-Lamy Syndrome).  Sufferers of MPS VI lack an enzyme in their blood that breaks down cellular waste in the body called glycosaminoglycan (GAG).  These GAGs build up in the bones, tissues, organs, and muscles of affected individuals and lead to many devastating symptoms including heart and airway disease, corneal clouding, stiffening of the joints, shortened stature, and premature death.  To date, there are 9 children suffering from the disease in Canada and roughly 1,100 worldwide.

While there is no known cure for MPS VI, a treatment does exist.  Naglazyme is an Enzyme-Replacement Therapy (ERT) designed to provide patients with a synthetic version of the enzyme they are lacking by infusing small doses into the patient’s bloodstream on a weekly basis.  Produced by Biomarin, the treatment for this orphan disease can range from $300,000 per year for a small individual to $1 million per year for a young adult.  Due to the lack of an orphan drug policy in Canada, Naglazyme is only available to Canadian patients through the Federal Government’s Special Access Program (SAP).  It is being used for patients in Ontario, British Columbia, Saskatchewan, and Quebec through the SAP and is funded by the Provincial governments respectively.  Currently, Naglazyme has been approved in numerous countries worldwide, including the United States, the European Union, and Australia.

In Canada, there are numerous precedents for the life-sustaining treatment to be funded.  The first approved case took place in Ontario where the parents of 9 year-old Isaac McFadyen, residents of Campbellford, Ontario, successfully lobbied the Government to fund the expensive Enzyme Replacement Therapy for him when he was diagnosed in 2006.  After a very public campaign to secure funding, Isaac has been receiving his weekly infusions at The Hospital For Sick Children in Toronto for 7 years.  Since then, numerous other provinces have used the precedent set by the McFadyen case and have approved the same treatment for their patients, most recently in 2012 in Saskatchewan and 2011 in Ontario.

Prior to starting treatment, Isaac suffered from severe compression of his spinal cord that required the removal of a piece of his skull and a portion of his vertebrae.  In addition, Isaac endured numerous other surgeries to treat complications of the advancing disease in his body.   Since beginning his weekly infusions, Isaac’s liver and spleen have reduced back down to a normal size, his rate of growth has increased, his heart function has improved, and his heart valve disease has stabilized.  Furthermore, Isaac has had no further progression of his bone and joint disease, airway disease, and compression of his spinal cord.

Naturally, the Sadownyk family has been devastated by the diagnosis of their daughter, Aleena.  Laura Sadownyk, Aleena’s mother, expressed her fears about the length of time the government is taking to render its decision.  “It’s very agonizing to wait patiently, especially after hearing the experts in this field talk about early diagnosis and treatment being the best way to prevent the onset of a lot of the effects of this disease.”

McFadyen also notes how important it is to get children affected with MPS VI started on weekly infusions at a young age, and is also frustrated by the process put in place to review rare disease funding in the province.  “We know that this treatment can slow down or even halt the disease progression in individuals so it’s very important to begin treatment as soon as possible after diagnosis.  Aleena has already been approved by the Special Access Program to receive the treatment she so desperately needs.  The only thing stopping her from beginning that treatment is the lack of funding by the Province.”  Adds Sadownyk, “It’s heartbreaking that the fate of our daughter rests in the hands of bureaucrats.”

McFadyen believes that the time for action from the Redford government is now.  “The Provincial government has the opportunity to do the right thing and ensure that Aleena receives the treatment she so desperately needs.  It’s the role of government to protect and ensure fair and equitable access to Health Care for all Canadians, regardless of which Province they happen to live it.  The Isaac Foundation is calling on this government to take action and save the life of this child.  She can’t afford to wait.”

#  #  #

For more information about this topic, or to schedule an interview to discuss, please call Andrew at 613-328-9136 or email Andrew at mcfadyena@me.com.

Attached Photo – Aleena Sadownyk, Age 3.  St. Albert, AB
4d5f8030f60e11e2ad2b22000ae80c6b_7

#Treatment4Aleena

photo 1-2Hi Everyone,

As a educator, I often look for ways to help our children become empathetic, caring, and compassionate individuals.  When kids leave my classroom, I want them to strive to make the world a better place; I want them to understand that they CAN make a difference in the greater world around them.  I want them to know the importance of helping others.

There are many ways that teachers help guide their students along the path to caring – books, news articles, projects, and fundraising activities all come to mind as examples I see in schools across this country.  All of these activities are well and good in the classroom, but none of it matters if we don’t stand in front of our children and lead by example.  None of it matters if our students don’t see us practicing what we’re preaching.  To me, taking a moment to fight to save the life of Aleena Sadownyk (pictured left) should be on top of everyone’s list of “To Do’s” today as we seek to set that example for our kids.

3 1/2 year old Aleena Sadownyk was recently diagnosed with an ultra-rare enzyme deficiency called MPS VI.  Essentially, Aleena lacks an enzyme in her blood responsible for breaking down cellular waste in her body.  This waste then builds up and stores in her bones, tissues, organs, and muscles.  Progressively, this disease devastates the body.  Internal organs begin to swell, joints begin to stiffen, and heart and airway disease begin to take over.  Along with a host of other catastrophic symptoms, this disease can lead to a shortened stature and a severely shortened life span.

isaac10lf4

When a child is diagnosed with this disease – and there are only 9 children fighting this in Canada – the news is devastating.  I know this because my son, Isaac (right), was diagnosed in 2006 at the age of 18 months.  At that time, we were told that our beautiful little boy may not reach his teens and that the years leading up to those teenage years would be filled with painful surgeries and horrific symptoms.  My wife and I were sick with fear – I lost 40 pounds in a few weeks, and we were devastated that the future for our little boy was forever changed.  At that time, Hope seemed lost.

However, we soon learned that Hope wasn’t lost.  A treatment for this disease was available, albeit not in Canada.  The treatment consists of a weekly infusion of a synthetic version of the enzyme that children affected with MPS VI lack.  Studies have shown that this treatment dramatically slows the progress of the disease, if not halt it altogether.  It’s not a cure, but it is certainly a lifeboat for our children until a cure can be found.  Because we lack an Orphan Drug Policy here in Canada, we had to apply to have this treatment brought to Canada using the Federal Government’s Special Access Program (SAP).  We were quickly granted the right to bring the treatment (ERT) to Canada – contingent on the province funding the administration of it to our Isaac.  And herein lies the problem – treatment costs for a small child can start around $300,000 annually and escalate to $1,000,000 for a young teenager.

photo 3-1

Through our heartfelt lobbying of the Ontario Liberal Government, assisted by the tireless advocacy of MPP Elizabeth Witmer, we were successful in securing funding for Isaac.  Today, because of his treatment, Isaac is a happy 9-year old boy who loves to read, play with his toys, play piano, and spend time with his best friend, his younger brother Gabriel.

The battle for Isaac’s life was won, a battle that should never have taken place in the first place.  With the success of Isaac’s fight, and the obvious benefits to the treatment that the government was now funding, it should have been easy for Aleena’s family to get a quick approval for the same treatment.  After all, our Health Care System is designed to provide Equal Access to All – we’re set up to ensure the best care for all Canadians regardless of age, gender, religious beliefs – regardless of anything.  To bolster the case for providing treatment, ERT is already funded in numerous provinces across Canada, including BC, Saskatchewan, Ontario, and Quebec.  As well, ERT is already approved in the United States, the European Union, Australia, and other developed countries!  In fact, treating MPS VI with ERT is the standard of care in these countries.

But on a few weeks ago, Aleena’s family got the heartbreaking news that the Alberta Government had denied funding for the Life-Sustaining treatment that Aleena needs – the exact same treatment they are currently funding for Isaac McFadyen in Ontario.  And Jasper More in Ontario.  And Violet Revet in Saskatchewan.  And the list goes on!  Aleena’s parents, and our family, were stunned by the news.  How can we allow this disease to ravage Aleena when we know we can stop it?

Thus began our battle anew, and we’ve had to cross  government officials again in order to advocate for the life of a little girl.  As a member of the federal Liberal Party, and as an aspiring Politician, I’ve talked at length about preserving our Social Safety Net – standing up for those in need, protecting the most vulnerable in our society, and fighting for what I believe in.  Doing the right thing is never easy, and working to save Aleena’s life is the right thing.  Whatever the cost, this is a step we need to take in order to ensure that Aleena gets the same opportunity that my son has had.  The same opportunity that Jasper has had…and Violet.  The same opportunity all Canadians have – the right to a long and healthy life, with the proper access to our health care system in her time of need.

photo 4

Over the coming days, we’re going to need help.  A decision on the second application to Alberta Health is expected soon.  How long?  We don’t know because we can’t get an accurate timeline as to when the decision making process will be complete.  Essentially, the fate of Aleena is in the hands of a few select bureaucrats who get to say yes or no to funding the life-sustaining treatment Aleena needs.  To everyone out there that has supported The Isaac Foundation throughout the years, please stand ready.  Ready to help us advocate, ready to make a difference for Aleena.  We’ll update more as things progress as to what you can do to help.

I’ll sign off this overly long (sorry!) blog update by explaining our Foundation Slogan.  We chose “Love, Laughter, and Hope” because our son gives us the first two each and every day.  But sometimes, all you have left is Hope.  Aleena and her Family need all the hope they can get these days, and I’ll thank you in advance for providing that.

With Thanks,

A.